The purpose of this research study is to evaluate the effect of atomoxetine (also known as
Strattera) compared to placebo (inactive substance) on daily activities such as attention and
focus, thinking ability and muscle movements in subjects with early Huntington Disease (HD)
and attention deficit disorder (ADD).